IP Library › Granted Patent US 8,710,245
Granted Patent B2
US 8,710,245 · App. 13/513,176 · Granted Apr 29, 2014

Multicyclic compounds and methods of use thereof

Inventors: Liming Shao (Lincoln, MA); John Emmerson Campbell (Cambridge, MA); Michael Charles Hewitt (Somerville, MA); Una Campbell (Marlborough, MA); Taleen G. Hanania (Valhalla, NY)
Assignees: PsychoGenics Inc.; Sunovion Pharmaceuticals Inc.
C07D495/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,710,245
App. No.
13/513,176
Granted
Apr 29, 2014
Kind
B2
Abstract

Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.

Claims (87)

1. A compound of formula (IVa):

or a pharmaceutically acceptable salt or stereoisomer thereof, wherein:

m is 0;

n is 1;

R 1 and R 2 are each independently hydrogen or C 1 -C 4 alkyl;

R 3 and R 4 are each independently hydrogen or C 1 -C 4 alkyl;

R 5 is hydrogen; and

R 6 and R 7 are each independently hydrogen, halo, or C 1 -C 4 alkyl.

2. The compound of claim 1 , or a pharmaceutically acceptable salt or stereoisomer thereof, wherein R 3 and R 4 are each hydrogen and R 6 and R 7 are each independently hydrogen, or C 1 -C 4 alkyl.

3. The compound of claim 1 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

4. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

5. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

6. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

7. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

8. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

9. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

10. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

11. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

12. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

13. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

14. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

15. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

16. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

17. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

18. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

19. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

20. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

21. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

22. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

23. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

24. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

25. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

26. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

27. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

28. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

29. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

30. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

31. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

32. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

33. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

34. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

35. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

36. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

37. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

38. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

39. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

40. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

41. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2016
From: PSYCHOGENICS INC.
To: PGI DRUG DISCOVERY LLC.
Reel/Frame 037434/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2016
From: HANANIA, TALEEN G.
To: PSYCHOGENICS INC.
Reel/Frame 037413/0506 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2014
From: SHAO, LIMING; CAMPBELL, JOHN EMMERSON; HEWITT, MICHAEL CHARLES; CAMPBELL, UNA
To: SUNOVION PHARMACEUTICALS INC.
Reel/Frame 034148/0047 →
Continuity (2)
Provisional Application 61266880 · Dec 4, 2009
Related Publication 20130109677A1 · May 2, 2013